Capricor Therapeutics Inc...

NASDAQ: CAPR · Real-Time Price · USD
7.08
-0.59 (-7.69%)
At close: Aug 20, 2025, 1:25 PM

Capricor Therapeutics Revenue

Capricor Therapeutics reported an annual revenue of $22.27M, reflecting a -11.55% growth. For the quarter ending June 30, 2025, Capricor Therapeutics generated $0 in revenue.
Revenue (ttm)
22.27M
Revenue Growth
-11.55%
Price / Sales Ratio
21.82
Revenue / Employee
139.19K
Employees
160
Market Cap
323.45M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 22.27M -11.55%
Dec 31, 2023 25.18M +886.99%
Dec 31, 2022 2.55M +941.66%
Dec 31, 2021 244.9K -21.06%
Dec 31, 2020 310.25K -69.13%
Dec 31, 2019 1M -39.86%
Dec 31, 2018 1.67M -37.32%
Dec 31, 2017 2.67M -16.43%
Dec 31, 2016 3.19M -15.52%
Dec 31, 2015 3.78M -9.38%
Dec 31, 2014 4.17M +728.05%
Dec 31, 2013 503.23K +157.41%
Dec 31, 2012 195.5K -85.57%
Dec 31, 2011 1.35M +Infinity%
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 -100.00%
Dec 31, 2007 101.4K -73.37%
Dec 31, 2006 380.83K +Infinity%
Dec 31, 2005 0 n/a
Dec 31, 2004 0 -100.00%
Dec 31, 2003 2.18K -80.98%
Dec 31, 2002 11.48K +Infinity%
Dec 31, 2001 0 n/a
Dec 31, 2000 0 n/a
Dec 31, 1999 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.